Latest Insider Transactions at Mind Medicine (Mind Med) Inc. (MNMD)
This section provides a real-time view of insider transactions for Mind Medicine (Mind Med) Inc. (MNMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mind Medicine (MindMed) Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mind Medicine (MindMed) Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,350
-0.52%
|
$0
$0.68 P/Share
|
|
Aug 11
2022
|
Roger Crystal |
BUY
Grant, award, or other acquisition
|
Direct |
89,286
+50.0%
|
-
|
|
Aug 11
2022
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
89,286
+50.0%
|
-
|
|
Jul 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,856
-0.24%
|
$0
$0.69 P/Share
|
|
Jul 25
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,361
-0.21%
|
$0
$0.69 P/Share
|
|
Jul 25
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,681
-0.48%
|
$0
$0.69 P/Share
|
|
Jul 18
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,388
-0.49%
|
$0
$0.7 P/Share
|
|
Jun 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,238
-0.64%
|
$0
$0.7 P/Share
|
|
Jun 27
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,762
-0.93%
|
$0
$0.7 P/Share
|
|
Jun 16
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,275
-0.54%
|
$0
$0.7 P/Share
|
|
Jun 01
2022
|
Andreas Krebs |
BUY
Grant, award, or other acquisition
|
Direct |
21,552
+50.0%
|
-
|
|
Jun 01
2022
|
Brigid Makes Director |
BUY
Grant, award, or other acquisition
|
Direct |
64,656
+28.95%
|
-
|
|
Jun 01
2022
|
Carol A Vallone |
BUY
Grant, award, or other acquisition
|
Direct |
43,104
+50.0%
|
-
|
|
May 27
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,555
-0.23%
|
$0
$0.82 P/Share
|
|
May 25
2022
|
Dan Karlin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,242
-0.2%
|
$0
$0.77 P/Share
|
|
May 25
2022
|
Robert Barrow Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,415
-0.46%
|
$0
$0.77 P/Share
|
|
May 23
2022
|
Schond L. Greenway Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,270,000
+50.0%
|
-
|
|
May 15
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,948
-0.47%
|
$0
$0.82 P/Share
|
|
May 11
2022
|
Brigid Makes Director |
BUY
Other acquisition or disposition
|
Direct |
67,678
+41.85%
|
-
|
|
Apr 26
2022
|
Dan Karlin Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,038
-0.32%
|
$0
$0.81 P/Share
|
|
Apr 18
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,110
-0.47%
|
$0
$0.92 P/Share
|
|
Mar 28
2022
|
Dan Karlin Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,203
-0.25%
|
$10,203
$1.17 P/Share
|
|
Mar 24
2022
|
Dan Karlin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
950,000
+18.74%
|
-
|
|
Mar 24
2022
|
Miri Halperin Wernli Executive President |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+32.0%
|
-
|
|
Mar 24
2022
|
Cynthia W. Hu Chief Legal Officer&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+50.0%
|
-
|
|
Mar 24
2022
|
Robert Barrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,820,000
+31.09%
|
-
|
|
Mar 15
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,612
-0.57%
|
$12,612
$1.0 P/Share
|
|
Feb 26
2022
|
Dan Karlin Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
118,143
-3.59%
|
$118,143
$1.21 P/Share
|
|
Feb 15
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,734
-0.83%
|
$18,734
$1.35 P/Share
|
|
Feb 10
2022
|
Carrie Liao Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
403,430
+50.0%
|
-
|
|
Jan 15
2022
|
Robert Barrow Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
190,287
-7.81%
|
$190,287
$1.05 P/Share
|